Omni Partners’s Imperva, Inc. IMPV Stock Holding History

Omni Partners’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-96,500	Closed	-$5.18M	–	23
2016 Q3	$5.18M	Buy	+96,500	New	+$4.48M	1.51%	16

Other funds holding IMPV

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Litespeed Management New York $48.2M AUM 9.81% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Omni Partners's IMPV Position: Q4 2016 in Review

Omni Partners sold out of Imperva, Inc. (IMPV) in Q4 2016, closing a stake of 96,500 shares — an estimated $5.18M sold.

Omni Partners first reported a position in IMPV in Q3 2016 and held it in 1 quarter. The position peaked at $5.18M in Q3 2016. 172 funds tracked by Wall St. Rank hold IMPV as of Q4 2016.

Omni Partners reported no remaining Imperva, Inc. position as of Q4 2016 after selling out during the quarter.
Omni Partners sold 96,500 Imperva, Inc. shares in Q4 2016, an estimated $5.18M.
Omni Partners first reported a position in Imperva, Inc. in Q3 2016 and held it in 1 quarter.
Omni Partners's Imperva, Inc. position peaked at $5.18M in Q3 2016.
172 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2016.

Based on Omni Partners's 13F filing for Q4 2016, filed 15 Feb 2017.